We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+8.94%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$76.2B
AUM Growth
+$2.6B
(+3.5%)
Cap. Flow
-$2.97B
Cap. Flow
% of AUM
-3.9%
Top 10 Holdings %
Top 10 Hldgs %
21.61%
Holding
3,238
New
235
Increased
684
Reduced
2,065
Closed
243
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$77.3M |
| 2 |
Blackstone
BX
|
+$53.2M |
| 3 |
NXP Semiconductors
NXPI
|
+$40.8M |
| 4 |
Palantir
PLTR
|
+$34.3M |
| 5 |
Snowflake
SNOW
|
+$24.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$206M |
| 2 |
Microsoft
MSFT
|
+$163M |
| 3 |
Linde
LIN
|
+$133M |
| 4 |
Amazon
AMZN
|
+$94.7M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$82.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.34% |
| 2 | Financials | 14.16% |
| 3 | Healthcare | 12.95% |
| 4 | Consumer Discretionary | 12.06% |
| 5 | Communication Services | 9.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2026
MacroGenics
MGNX
$257M
| $1.66M | ﹤0.01% |
61,888
-16,904
| -21% | -$495K |
|
|
RDUS
2027
DELISTED
Radius Recycling
RDUS
| $1.66M | ﹤0.01% |
33,862
-5,060
| -13% | -$252K |
|
|
LGF.A
2028
DELISTED
Lions Gate Entertainment Corp. Class A Voting Shares
LGF.A
| $1.66M | ﹤0.01% |
80,221
+22,667
| +39% | +$397K |
|
2029
Marcus Corp
MCS
$945M
| $1.65M | ﹤0.01% |
77,946
-2,689
| -3% | -$55.9K |
|
2030
Sotera Health
SHC
$5.38B
| $1.65M | ﹤0.01% |
68,218
+17,564
| +35% | +$432K |
|
2031
Huron Consulting
HURN
$2.42B
| $1.65M | ﹤0.01% |
33,563
-4,154
| -11% | -$223K |
|
|
SGMO
2032
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $1.65M | ﹤0.01% |
137,815
-6,695
| -5% | -$75.8K |
|
2033
Camping World
CWH
$653M
| $1.64M | ﹤0.01% |
40,102
+5,785
| +17% | +$239K |
|
|
RIDE
2034
DELISTED
Lordstown Motors Corp. Class A Common Stock
RIDE
| $1.64M | ﹤0.01% |
+9,908
| New | +$1.52M |
|
2035
Yext
YEXT
$574M
| $1.63M | ﹤0.01% |
114,049
-5,497
| -5% | -$76.5K |
|
2036
American Public Education
APEI
$940M
| $1.63M | ﹤0.01% |
57,395
+718
| +1% | +$21.7K |
|
2037
Senseonics Holdings Inc
SENS
$366M
| $1.63M | ﹤0.01% |
+21,168
| New | +$1.07M |
|
2038
Malibu Boats
MBUU
$567M
| $1.63M | ﹤0.01% |
22,156
-2,059
| -9% | -$164K |
|
2039
REX American Resources
REX
$1.41B
| $1.62M | ﹤0.01% |
107,826
-7,524
| -7% | -$109K |
|
2040
ATN International
ATNI
$492M
| $1.62M | ﹤0.01% |
35,600
-2,445
| -6% | -$117K |
|
2041
IMAX
IMAX
$2.66B
| $1.62M | ﹤0.01% |
75,273
+435
| +0.6% | +$9.37K |
|
|
CDMO
2042
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
| $1.62M | ﹤0.01% |
63,096
-4,224
| -6% | -$90.2K |
|
2043
Cooper-Standard Automotive
CPS
$558M
| $1.62M | ﹤0.01% |
55,719
-3,554
| -6% | -$110K |
|
|
JAMF
2044
DELISTED
Jamf
JAMF
| $1.61M | ﹤0.01% |
48,102
+13,413
| +39% | +$457K |
|
2045
ADT
ADT
$5.58B
| $1.61M | ﹤0.01% |
149,190
-2,336
| -2% | -$23.5K |
|
2046
The RMR Group
RMR
$332M
| $1.61M | ﹤0.01% |
41,658
+1,956
| +5% | +$77.9K |
|
2047
Scorpio Tankers
STNG
$3.81B
| $1.61M | ﹤0.01% |
72,859
-12,653
| -15% | -$257K |
|
2048
PAR Technology
PAR
$735M
| $1.6M | ﹤0.01% |
22,938
+3,851
| +20% | +$273K |
|
|
CONN
2049
DELISTED
Conn's Inc.
CONN
| $1.6M | ﹤0.01% |
62,898
-2,756
| -4% | -$63.7K |
|
|
EGRX
2050
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $1.6M | ﹤0.01% |
37,381
+933
| +3% | +$38.5K |
|
Similar funds
VAM
RhumbLine Advisers's Q2 2021 Portfolio in Review
As of Q2 2021, RhumbLine Advisers held 3,238 positions worth $76.2B, up 3.5% from $73.6B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
RhumbLine Advisers withdrew a net $2.97B in Q2 2021, closing 243 positions and reducing 2,065 holdings. Its most notable exit was Varian Medical Systems, Inc., an estimated $32.1M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.
Against the trend, RhumbLine Advisers opened a new position in DraftKings worth $14.2M.
- RhumbLine Advisers's largest Q2 2021 buy was DraftKings: 271,227 shares worth $14.2M.
- RhumbLine Advisers added most to iShares Core S&P 500 ETF in Q2 2021, an estimated $77.3M increase.
- RhumbLine Advisers's biggest Q2 2021 reduction was Apple, cutting an estimated $206M.
- RhumbLine Advisers fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $32.1M.
- RhumbLine Advisers's ten largest holdings make up 22% of its $76.2B portfolio in Q2 2021.
- RhumbLine Advisers opened 235 new positions and closed 243 in Q2 2021.
- RhumbLine Advisers's portfolio value rose 3.5% quarter-over-quarter to $76.2B.
Based on RhumbLine Advisers's 13F filing for Q2 2021, filed 5 Aug 2021.